Soroka Medical Center
Beersheba, 84101, Israel
NCT Number: NCT00292812
The study hypothesis is that different concentrations of nucleotides' supplementation of an infant formula might affect differently growth and/or other clinical parameters in neonates.
Looking for future studies?
Notify Me1 day–30 day
All sexes
Interventional
Not applicable
Beersheba, 84101, Israel
Three groups of 50 newborn infants each, will be fed for 30 days an infant formula supplemented with either 4.9 mg/100 kcal or 10.6 mg/100 kcal of nucleotides or with no supplementation. Newborns will be monitored prospectively for the following outcome parameters:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Soroka University Medical Center
Other
The Clinical Effects of an Infant Formula Supplemented With Various Concentrations of Nucleotides
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04287816
Nutritional Requirements
Columbus, Ohio, United States
View Trial DetailsNCT04286321
Nutritional Requirements
Columbus, Ohio, United States
View Trial DetailsNCT04419103
Nutritional Requirements
Dezhou, Shandong, China
View Trial DetailsNCT00803699
Nutritional Requirements
Grand Forks, North Dakota, United States
View Trial Details